Trials on trial: 'short-term pain' needed for broken clinical enterprise
This article was originally published in SRA
Executive Summary
A comprehensive redesign of the entire clinical trial enterprise must be considered if the deficit of evidence underpinning clinical practice guidelines is to be tackled, say researchers from Duke University in JAMA1.